| Therapeutic Potential for Tetracyclines in the Treatment of COVID‐19 M Sodhi, M Etminan Pharmacotherapy 40 (5), 487, 2020 | 134 | 2020 |
| Safety of ibuprofen in patients with COVID-19: causal or confounded? M Sodhi, M Etminan Chest 158 (1), 55, 2020 | 110 | 2020 |
| Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss M Sodhi, R Rezaeianzadeh, A Kezouh, M Etminan Jama 330 (18), 1795-1797, 2023 | 65 | 2023 |
| Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study M Etminan, M Sodhi, A Samii, RM Procyshyn, M Guo, BC Carleton Journal of clinical psychopharmacology 37 (1), 102-104, 2017 | 56 | 2017 |
| Oral fluoroquinolones and risk of mitral and aortic regurgitation M Etminan, M Sodhi, S Ganjizadeh-Zavareh, B Carleton, A Kezouh, ... Journal of the American College of Cardiology 74 (11), 1444-1450, 2019 | 46 | 2019 |
| Potential Biases in Studies of Acid Suppressing Drugs and COVID-19 Infection M Etminan, M Nazemipour, M Sodhi, M MA. Gastroenterology 5085 (20), 35550-5, 2020 | 34 | 2020 |
| Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: nested case-control study M Sodhi, CA Sheldon, B Carleton, M Etminan Neurology 89 (8), 792-795, 2017 | 33 | 2017 |
| Risk of ocular adverse events associated with use of phosphodiesterase 5 inhibitors in men in the US M Etminan, M Sodhi, FS Mikelberg, D Maberley JAMA ophthalmology 140 (5), 480-484, 2022 | 22 | 2022 |
| Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases M Etminan, M Sodhi, A Samii, BC Carleton, A Kezouh, JA Avina-Zubieta Seminars in Arthritis and Rheumatism 48 (6), 1083-1086, 2019 | 13 | 2019 |
| Statin medications and the risk of gynecomastia SC Skeldon, B Carleton, JM Brophy, M Sodhi, M Etminan Clinical Endocrinology 89 (4), 470-473, 2018 | 12 | 2018 |
| Fluoroquinolone use and risk of carpal tunnel syndrome: a pharmacoepidemiologic study JZ Cheng, M Sodhi, M Etminan, BC Carleton Clinical Infectious Diseases 65 (4), 684-686, 2017 | 12 | 2017 |
| A review of robotic surgical training: establishing a curriculum and credentialing process in ophthalmology B He, MD de Smet, M Sodhi, M Etminan, D Maberley Eye 35 (12), 3192-3201, 2021 | 11 | 2021 |
| Should antipyretics be used to relieve acute adverse events related to COVID-19 vaccines? M Etminan, M Sodhi, S Ganjizadeh-Zavareh Chest 159 (6), 2171-2172, 2021 | 11 | 2021 |
| Non‐steroidal anti‐inflammatory drugs and the risk of pneumonia complications: a systematic review M Sodhi, F Khosrow‐Khavar, JM FitzGerald, M Etminan Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40 (9 …, 2020 | 11 | 2020 |
| Risk of hair loss with different antidepressants: a comparative retrospective cohort study. M Etminan, M Sodhi, RM Procyshyn, M Guo, BC Carleton International Clinical Psychopharmacology, doi: 10.1097/YIC.0000000000000191, 2017 | 11 | 2017 |
| Dentists’ prescribing of analgesics for children in British Columbia, Canada M Etminan, MR Nouri, M Sodhi, BC Carleton J Can Dent Assoc 83 (h5), 1488-2159, 2017 | 8 | 2017 |
| Risk of Ocular Adverse Events With Taxane-Based Chemotherapy M Sodhi, S Yeung, D Maberley, F Mikelberg, M Etminan JAMA Ophthalmology 140 (9), 880-884, 2022 | 7 | 2022 |
| Risk of sexual dysfunction with progestin-based contraceptives in women of child-bearing age MY Guo, M Sodhi, F Khosrow-Khavar, M Etminan European Journal of Clinical Pharmacology 77, 133-140, 2021 | 7 | 2021 |
| Oral Fluoroquinolones and Risk of Fibromyalgia S Ganjizadeh‐Zavareh, M Sodhi, T Spangehl, B Carleton, M Etminan British Journal of Clinical Pharmacology, 2018 | 7 | 2018 |
| Association of topical prostaglandin analogue use with risk of spontaneous abortion M Etminan, L Richter, M Sodhi, FS Mikelberg JAMA ophthalmology 140 (6), 634-636, 2022 | 6 | 2022 |
Mahyar EtminanUniversity of British ColumbiaVerified email at mail.ubc.ca
